Why Is NIV Recommended for Neuromuscular Chronic Respiratory Failure?
Question
Why Is NIV Recommended for Neuromuscular Chronic Respiratory Failure?
Answer
The panel's recommendation of employing non-invasive ventilation aligns logically with this context. However, it is worth noting that while clinical indications for non-invasive ventilation exist, they can vary depending on factors such as the specific neuromuscular disease, patient age, and the pace of disease progression. In essence, these multifaceted variables influence the suitability of non-invasive ventilation.
The evidence was primarily derived from adults with ALS, given its prevalence as the most common NMD. However, its application should be approached thoughtfully when considering younger children, adolescents, and adults with non-ALS diagnoses. The panel further suggests that its applicability remains subject to these diverse factors even with established indications for non-invasive ventilation. The panel highlights key indicators, such as a decrease in forced vital capacity (FVC) to less than 80% of predicted, accompanied by symptoms or an FVC below 50% of predicted. Similarly, an SNIP or MIP measurement indicating a reserve of -40 centimeters of water can signal the need for non-invasive ventilation.
The guidelines have transitioned from recommendations and marked a significant development in 2023. Specifically, if a patient's FVC falls below 80% with symptoms or below 50% without symptoms, non-invasive ventilation should be implemented.
Duane Reed
EdD, RRT, RCP
Related Courses
Respiratory Management in Neuromuscular Weakness: Review of the Grading of Recommendations for Assessment, Development, and Evaluations
Clinical experts comprised a multi-professional panel to conduct a systematic review to address patients with neuromuscular diseases (NMD). A review of evidenced-based grading of recommendations and management of patients with NMD is discussed. It is part of an NMD series but can be viewed as a stand-alone learning experience.Revisiting Adverse Childhood Experiences: Is This the Key to Managing COPD
A landmark study conducted by Kaiser-Permanente established a solid relationship between adverse childhood experiences (ACEs) and the development of Chronic Obstructive Pulmonary Disease (COPD). This interactive lecture will provide an overview of the findings from this study as well as current literature associated with the topic. An advanced discussion will challenge those providers in post-acute settings to evaluate opportunities to break the cycle of disease and improve quality-of-life for our at-risk population through education and empowerment.Idiopathic Pulmonary Fibrosis: A Deadly Progressive Fibrotic Lung Disease
Idiopathic pulmonary fibrosis is a progressive fibrotic lung disease affecting individuals worldwide. This advanced course provides familiarity with current literature findings in epidemiology, pathology, and diagnosis of IPF. In addition, this course reviews future therapeutic directions and clinical applications for best practice and management.